Patil CR, Suryakant Gawli C, Bhatt S
Kybella is FDA approved for use in the area under the chin (submental region)
Moderate for other peptides based on mechanisms and preliminary research
If you inject on Monday, inject every Monday
Regulatory status as of July 26, 2026: The Pharmacy Compounding Advisory Committee issued favorable recommendations for BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax, and an unfavorable recommendation for emideltide/DSIP
Unfortunately, with the possible exception of LPS and I-FABP, validation of these assays against standard permeability measurements and proper clinical validation studies in large groups of patients are missing and can therefore not be recommended to replace the direct permeability tests described above